Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2005-7-25
pubmed:abstractText
The purpose of this study was to evaluate incidence and risk factors of secondary leukemia after adjuvant epirubicin-based chemotherapy in breast cancer patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1343-51
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15905306-Adult, pubmed-meshheading:15905306-Aged, pubmed-meshheading:15905306-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15905306-Breast Neoplasms, pubmed-meshheading:15905306-Chemotherapy, Adjuvant, pubmed-meshheading:15905306-Cyclophosphamide, pubmed-meshheading:15905306-Epirubicin, pubmed-meshheading:15905306-Female, pubmed-meshheading:15905306-Fluorouracil, pubmed-meshheading:15905306-Humans, pubmed-meshheading:15905306-Incidence, pubmed-meshheading:15905306-Leukemia, Myeloid, pubmed-meshheading:15905306-Middle Aged, pubmed-meshheading:15905306-Neoplasms, Second Primary, pubmed-meshheading:15905306-Randomized Controlled Trials as Topic, pubmed-meshheading:15905306-Risk Factors, pubmed-meshheading:15905306-Stereoisomerism, pubmed-meshheading:15905306-Survival Rate
pubmed:year
2005
pubmed:articleTitle
Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.
pubmed:affiliation
m-campone@nantes.fnclcc.fr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Meta-Analysis